TranS1 has completed first head-to-head retrospective study, designed for comparing its proprietary AxiaLIF pre-sacral interbody fusion procedure to Anterior Lumbar Interbody Fusion (ALIF). The trial has enrolled 48 patients in each arm ...
Tags: TranS1, retrospective study, AxiaLIF procedure, ALIF
Cytori Therapeutics has expanded its Celution system's CE mark approval to include several new indications including cryptoglandular fistula. The Celution system, which pulls stem cells and other regenerative cells out of fat , provides ...
Tags: Cytori Therapeutics, cryptoglandular fistula, celution system
OmniComm Systems has signed an agreement with Larix to support its clinical research needs for a five year, 31 site study. The partnership will enable Larix to provide its customers with quality products and services to manage complex ...
Target Health has launched a Verified Clinical Trials (VCT) database registry to halt dual enrollment in clinical trials. Verified Clinical Trials is a fully web based clinical research database registry tool designed specifically to ...
Tags: Target Health, VCT, verified clinical trials
Great Lakes Pharmaceuticals (GLPI) has selected OmniComm Systems' TrialMaster suite of applications to support clinical research needs for a multi-national pivotal device study involving up to 400 subjects across 20 sites. OmniComm will ...
Tags: Great Lakes Pharmaceuticals, GLPI, OmniComm systems, TrialMaster
Enzymotec has announced that clinical trials for its lipid-based ingredient line for infant nutrition yielded positive results.These large-scale clinical research trials were conducted on newborn term infants in several institutes globally. ...
Quanticate, a clinical research organization, has selected Comprehend Clinical data visualization and analytics platform. Comprehend Clinical has the ability to integrate into existing clinical systems and allows researchers to obtain ...
Tags: Quanticate, data visualization, analytics platform, Comprehend Clinical
Pharm-Olam International (POI) has signed a multi-year, multi-million dollar contract with Datatrak for the cloud-based unified clinical research solution, Datatrak One. The solution deployed worldwide through an ASP or Enterprise ...
Tags: Pharm-Olam International, POI
Quintiles and Allscripts have partnered to jointly develop software solutions for clinical and post-approval research. The collaboration focuses on late-phase research, recruiting for and monitoring of clinical trials, and post-market ...
Tags: Quintiles, software solutions for clinical, Allscripts
AB SCIEX has unveiled a new software application, LibraryView Software, which enables faster and reliable identification of contaminants in food, environmental, clinical research and forensic toxicology samples. The new software using ...
Tags: AB SCIEX, LibraryView Software, QTRAP and TripleTOF technologies
Aptiv Solutions has launched its proprietary suite of adaptive trial software, Addplan 6.0 PE. The Addplan 6.0 PE provides the statistical methodology, simulation and analysis tools for adaptive clinical trials that include an enrichment ...
Tags: Aptiv Solutions, adaptive trial software, Addplan 6.0 PE
Greenphire has signed a deal to provide its ClinCard technology platform to an undisclosed pharmaceutical company conducting a long-term clinical trial. Around 1,000 patients from six countries will participate in the five-year Phase III ...
JS Genetics has launched a new proprietary buccal swab test, XCAT-KS, to diagnose Klinefelter syndrome (KS) and other male sex chromosome aneuploidies. XCAT-KS is a PCR / pyrosequencing based bloodless test which identifies KS and ...
Tags: clinical research, clinical technology, proprietary DNA diagnostic tests
Saladax Biomedical has signed a distribution contract with INyDIA Labs for My5-FU, a test that measures levels of 5-fluorouracil (5-FU), in the blood of cancer patients, in Spain and Protugal. INyDIA will provide My5-FU test kits to ...
Tags: medical research, medical test, clinical research, company collaboration
The cancer genetic testing services provider, NeoGenomics has launched the first molecular assay, NeoType CLL for clinical use in the US, which detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1). The assay will offer ...
Tags: molecular assay, clinical research, clinical development